Home » FDA Clears Cepheid Xpert CT/NG Molecular Diagnostic Test
FDA Clears Cepheid Xpert CT/NG Molecular Diagnostic Test
Cepheid announced it has received clearance from the FDA to market Xpert CT/NG. Running on Cepheid’s GeneXpert Systems, Xpert CT/NG is a qualitative in vitro molecular diagnostic test for the detection and differentiation of Chlamydia trachomatis and Neisseria gonorrhoeae.
News Medical
News Medical
Upcoming Events
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May